Related Experiment Videos
Splenectomy for non-Hodgkin's lymphoma
1Department of Surgery, Hahnemann University, Philadelphia, PA 19102, USA.
American Journal of Clinical Oncology
|December 1, 1996
Summary
Splenectomy is a safe and effective treatment for non-Hodgkin's lymphoma (NHL) when indicated. This procedure can diagnose NHL, manage cytopenias, and relieve bulk symptoms with minimal complications.
Area of Science:
- Hematology
- Oncology
- Surgical Pathology
Background:
- Splenomegaly is a frequent complication of non-Hodgkin's lymphoma (NHL).
- It can cause significant symptoms and hematologic issues.
- Splenomegaly may be the initial presentation of NHL.
Purpose of the Study:
- To evaluate the safety and efficacy of splenectomy in patients with NHL.
- To assess splenectomy's role in diagnosis, cytopenia correction, and symptom relief for NHL.
Main Methods:
- Prospective review of 12 NHL patients undergoing splenectomy from July 1991.
- Indications included diagnosis, cytopenia management, and bulk symptom relief.
- Data collected on operative outcomes, complications, and hematologic response.
Main Results:
- No operative mortality or major morbidity; 17% experienced minor morbidity.
- Hemorrhage only in massive splenomegaly (>1,500g).
- 80% of cytopenias showed favorable response at 3 months post-surgery.
Conclusions:
- Splenectomy is a safe and effective option for selected NHL patients.
- It successfully addresses diagnostic needs, cytopenias, and bulk symptoms.
- Careful patient selection is crucial, especially regarding spleen size.